blog president aller

As a global leader in biomedical research and patient care, UAB continues to advocate ardently for sustained and predictable federal funding for the National Institutes of Health (NIH). The return on this federal investment in basic research at our nation’s research universities and other institutions is immense—in terms of new treatments and cures for devastating diseases, the training of the next generation of investigators and physicians, job creation and robust economic growth, and U.S. leadership in science and medicine.

This morning at a Senate Appropriations Subcommittee hearing on the FY18 NIH budget, NIH Director Francis Collins cited an example of groundbreaking NIH-supported research being conducted right here at UAB: Dr. Stephen Aller (Department of Pharmacology & Toxicology) is using a leading-edge technology called “cryo-EM” (a new form of electron microscopy) to greatly accelerate the development of drugs that could cure diseases such as Cystic Fibrosis, bringing hope to countless patients around our state, nation and world.

I invite you to watch this brief clip of the hearing that highlights Dr. Aller’s work (the video of the entire hearing may be viewed here). UAB is very proud of the impactful research being conducted by Dr. Aller and our other federally funded investigators, and we’re honored by this latest public recognition from NIH. 

My gratitude to all of our faculty, staff and students who are involved in such vital research, and to our Board of Trustees and our congressional delegation for their continued advocacy and support.